USP7 and neoplasm: On Day 16, the tumor volumes of mice orthotopically injected with USP7-silencing cell lines mice began to decline in comparison with control mice (Figure 10A,B), even though the tumors of MDA-MB-231-DoxR and MDA-MB-231-PtxR xenograft models had different growth rates.